Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial

Autor: Caimi, Paolo F *, Ai, Weiyun, Alderuccio, Juan Pablo, Ardeshna, Kirit M, Hamadani, Mehdi, Hess, Brian, Kahl, Brad S, Radford, John, Solh, Melhem, Stathis, Anastasios, Zinzani, Pier Luigi, Havenith, Karin, Feingold, Jay, He, Shui, Qin, Yajuan, Ungar, David, Zhang, Xiaoyan, Carlo-Stella, Carmelo
Zdroj: In The Lancet Oncology June 2021 22(6):790-800
Databáze: ScienceDirect